A Unique Domain of pRb2/p130 Acts as an Inhibitor of Cdk2 Kinase Activity
Open Access
- 1 August 1997
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 272 (34) , 20971-20974
- https://doi.org/10.1074/jbc.272.34.20971
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Retinoblastoma protein family in cell cycle and cancer: A reviewJournal of Cellular Biochemistry, 1996
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle.Proceedings of the National Academy of Sciences, 1995
- Cyclins, Cyclin-Dependent Kinases and Cdk Inhibitors: Implications in Cell Cycle Control and CancerCritical Reviews™ in Eukaryotic Gene Expression, 1995
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancersNature, 1994
- Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins.Genes & Development, 1993
- The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E.Genes & Development, 1993
- Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related proteinCell, 1991
- The E2F transcription factor is a cellular target for the RB proteinCell, 1991